Intellia Therapeutics NTLA

What to see in Intellia Therapeutics now

Is Wall Street adding or cutting?+24

328 13F filers hold it · +24 against the quarter before · shares held +30.3%

Holdings of 06/30

Who bought more than 5%?6.8%

State Street holds 6.8% · +1.3pp on the report before

Filed 08/07

328 13F filers hold it · +24 against the quarter before · shares held +30.3%Holdings of 06/30
State Street holds 6.8% · +1.3pp on the report beforeFiled 08/07

13F filers: 328 · +24 since the quarter before · 06/30 holdings

Famous funds that held Intellia Therapeutics in their latest 13F report.

Fund	Shares	Value	Share of the portfolio	Since the quarter before
ARK Investment ManagementIntellia Therapeutics NTLA · 06/30 holdings	16,875,684 sh	$285.5M	1.9%	Added +16.3%
Mirae Asset Global ETFS HoldingsIntellia Therapeutics NTLA · 06/30 holdings	201,803 sh	$3.4M	<0.1%	No quarter before
Mirae Asset Global InvestmentsIntellia Therapeutics NTLA · 06/30 holdings	6,249 sh	$105.7K	<0.1%	Added +1.4%

	Holder			Kind
08/07	State Street08/07	6.8%9,234,987 sh	+1.3pp	13G passive
04/30	Vanguard Capital Management04/30	5.03%5,945,571 sh	First report	13G passive
04/29	Vanguard Portfolio Management04/29	5.3%6,266,007 sh	First report	13G passive
03/27	Vanguard Group03/27	0%0 sh	−11.2pp	13G passiveAmendment
02/12	Goldman Sachs Group02/12	2.7%3,157,178.33 sh	−2.4pp	13G passiveAmendment
02/11	Contrarius Investment Management02/11	0.6%714,480 sh	−4.9pp	13G passiveAmendment
02/09	State Street02/09	5.5%6,418,836 sh	+1.1pp	13G passive
02/03	ARK Investment Management02/03	12.27%14,207,324 sh	+1.2pp	13G passiveAmendment
01/30	Vanguard Group01/30	11.23%13,010,001 sh	+1.2pp	13G passiveAmendment
25/11/12	Goldman Sachs Group25/11/12	5.1%5,498,262.38 sh	First report	13G passive
25/11/12	Contrarius Investment Management25/11/12	5.5%5,889,936 sh	First report	13G passive
25/05/13	State Street25/05/13	4.4%4,510,261 sh	First report	13G passive